The drug’s manufacturer, Bristol-Myers Squibb, will
charge $141,000 for the first 12 weeks of treatment and $256,000 for a year of
treatment, according to the Wall Street Journal. Experts fear the cost of the
drug could keep some patients from receiving what could be the best care
available.
When calculating the average cost for one extra year of life,
the researchers determined patients and insurers paid $54,100 in 1995. The
price for one year of life increased to $139,100 in 2005 and $207,000 in 2013.
https://www.drugwatch.com/2015/10/07/cost-of-cancer/
Comments
Healthcare
costs for treatment of life-threatening disease are unsustainable. Consumers need “stop-loss” coverage as their
highest priority.
Norb
Leahy, Dunwoody GA Tea Party Leader
No comments:
Post a Comment